iBio (IBIO) Depreciation and Depletion (2012 - 2026)

iBio (IBIO) has 15 years of Depreciation and Depletion data on file, last reported at $147000.0 in Q1 2026.

• On a quarterly basis, Depreciation and Depletion rose 21.49% year-over-year to $147000.0 in Q1 2026; TTM through Mar 2026 was $532000.0, a 4.52% increase from a year earlier, with the FY2025 full-year figure at $484000.0, down 24.14% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $147000.0, up from $141000.0 in the prior quarter.
• Over the last five years, Depreciation and Depletion for IBIO reached as high as $743000.0 in Q2 2022 and fell as low as $115000.0 in Q4 2022.
• Historically, Depreciation and Depletion has averaged $215176.5 across 5 years, with a median of $146000.0 in 2024.
• Across the five-year window, Depreciation and Depletion jumped 495.8% in 2022 and sank 83.07% in 2023, its largest moves.
• Year by year, Depreciation and Depletion stood at $115000.0 in 2022, then soared by 42.61% to $164000.0 in 2023, then decreased by 25.61% to $122000.0 in 2024, then advanced by 15.57% to $141000.0 in 2025, then advanced by 4.26% to $147000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $147000.0 in Q1 2026, $141000.0 in Q4 2025, and $123000.0 in Q3 2025.